Abstract:One major pathological hallmark of Alzheimer's disease (AD) is formation of senile plaques, whose major components are small peptides called beta-amyloid (Abeta) that are derived from beta-amyloid precursor protein (APP) through sequential cleavages by beta-secretase (BACE1) and gamma-secretase complex. APP, BACE1 and gamma-secretase complex components are transported through the secretory pathway; and Abeta can be generated at various sub cellular compartments depending on the interaction between APP and BACE1/gamma-secretase. Therefore, dysregulated trafficking of these proteins will affect Abeta generation and contribute to disease pathogenesis. Sorting nexin (SNX) family proteins are a diverse group of cellular trafficking factors that are unified by the presence of a phospholipid-binding motif - the PX domain. The ability of these proteins to bind specific phospholipids, as well as their propensity to form protein-protein complexes, points to a role for these proteins in membrane trafficking and protein sorting. However, information on regulation of AD proteins by SNX members is limited. We modulated the levels of different SNX family members in cell cultures and studied their effects on intracellular trafficking of APP, BACE1, and gamma-secretase components. In addition, we studied whether SNX family members affect APP processing/Abeta generation and the activities of BACE1 and gamma-secretase. Furthermore, we investigated the levels of SNX family members in the brain of patients with AD or other neurodegenerative diseases. We found that some SNX family members can regulate intracellular trafficking of BACE1 and gamma-secretase and thus affect APP processing for Abeta generation. Moreover, we found that the levels of certain SNX family members were altered in the brain of neurodegenerative disease patients when compared to control samples. Our results suggest that certain SNX members regulate intracellular trafficking of BACE1 and gamma-secretase and participate in the pathogenesis of AD and other neurodegenerative diseases.

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

SNX12 Affects Aβ Generation Through Regulating Subcellular Localization of BACE1

Sorting Nexin 12 Interacts with BACE1 and Regulates BACE1-mediated APP Processing

SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse

Roles of SNX Family Members in Neurodegenerative Diseases

Sorting Nexin 27 Regulates Aβ Production Through Modulating Γ-Secretase Activity

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

Exosomes Mediate APP Dysregulation <i>via</i> APP-miR-185-5p Axis

App Regulates Ngf Receptor Trafficking And Ngf-Mediated Neuronal Differentiation And Survival

Snx27 and Sorla Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

Delta-secretase Cleaves Amyloid Precursor Protein and Regulates the Pathogenesis in Alzheimer's Disease

Amyloid Precursor Protein Revisited

Regulatory Role Of Golgi Brefeldin A Resistance Factor-1 In Amyloid Precursor Protein Trafficking, Cleavage And A Beta Formation

Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy

Amyloid Precursor Protein-Mediated Endocytic Pathway Disruption Induces Axonal Dysfunction and Neurodegeneration.

SCG10 Promotes Non-Amyloidogenic Processing of Amyloid Precursor Protein by Facilitating Its Trafficking to the Cell Surface.

Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms